Large-scale testing (Phase 3)Study completedNCT06921759
What this trial is testing
Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
Who this might be right for
Atopic Hand and Foot Dermatitis
Eli Lilly and Company 221